News
Age-related macular degeneration (AMD) is a progressive eye disease where the macula – the part of the retina responsible for central vision – ...
Galimedix Therapeutics completed the single ascending dose part of a phase 1 study of GAL-101, a potential oral therapy under ...
Christine A. Curcio, Ph.D., and Cynthia Owsley, Ph.D. Christine A. Curcio, Ph.D., and Cynthia Owsley, Ph.D., were jointly ...
At ARVO 2025, in Salt Lake City, Utah, Ferhina Ali, MD, MPH, talked about her presentation on the early real-world use of aflibercept 8 mg in treatment-naive patients with neovascular age-related macu ...
Steven T. Reed, O.D., discusses age-related macular degeneration (AMD), the leading cause of severe vision loss in adults ...
Sylentis recently announced topline results from the SYL1801_II phase 2a study investigating SYL1801 for the treatment of ...
The VR experiences feature videos showing real people — actors portraying relatives and caregivers — interacting with users, ...
You can improve your eyesight with exercises and lifestyle changes, as well as corrective lenses and procedures. Find a list ...
Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.
In this Healio Video Perspective, Michael A. Singer, MD, discusses promising results for migaldendranib for the treatment of ...
If you are diabetic, keep it under control. Eat fruits and vegetables to get antioxidant vitamins. Eat fish and nuts like ...
At ARVO 2025, in Salt Lake City, Utah, Diana Do, MD, gave an update on the LIGHTSITE III study of photobiomodulation for dry age-related macular degeneration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results